Last reviewed · How we verify
glucosamine and chondroitin sulfate plus Prednisolone
glucosamine and chondroitin sulfate plus Prednisolone is a Small molecule drug developed by Ardabil University of Medical Sciences. It is currently FDA-approved.
At a glance
| Generic name | glucosamine and chondroitin sulfate plus Prednisolone |
|---|---|
| Sponsor | Ardabil University of Medical Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Prednisolone and Chloroquine Add on Therapy in Osteoarthritis of the Knee (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- glucosamine and chondroitin sulfate plus Prednisolone CI brief — competitive landscape report
- glucosamine and chondroitin sulfate plus Prednisolone updates RSS · CI watch RSS
- Ardabil University of Medical Sciences portfolio CI
Frequently asked questions about glucosamine and chondroitin sulfate plus Prednisolone
What is glucosamine and chondroitin sulfate plus Prednisolone?
glucosamine and chondroitin sulfate plus Prednisolone is a Small molecule drug developed by Ardabil University of Medical Sciences.
Who makes glucosamine and chondroitin sulfate plus Prednisolone?
glucosamine and chondroitin sulfate plus Prednisolone is developed and marketed by Ardabil University of Medical Sciences (see full Ardabil University of Medical Sciences pipeline at /company/ardabil-university-of-medical-sciences).
What development phase is glucosamine and chondroitin sulfate plus Prednisolone in?
glucosamine and chondroitin sulfate plus Prednisolone is FDA-approved (marketed).